Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $70.13 USD
Change Today +0.59 / 0.85%
Volume 2.0M
As of 4:15 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. Bertolini

Independent Director, Chairman of Strategic Planning & Capital Allocation Committee, Member of Executive Committee and Member of Audit Committee, Charles River Laboratories International, Inc.
AgeTotal Calculated CompensationThis person is connected to 63 board members in 6 different organizations across 9 different industries.

See Board Relationships
54$266,331

Background*

Mr. Robert J. Bertolini, also known as Bob, served as the President and Chief Financial Officer of Bausch & Lomb Holdings Incorporated since February 25, 2013. Mr. Bertolini served as the President and Chief Financial Officer of Bausch & Lomb Incorporated, Bausch & Lomb Holdings Incorporated, a subsidiary of Bausch & Lomb Holdings Incorporated. He served as the Chief Financial Officer and Executive Vice President at Merck & Co. Inc. He has an extensive experience in ...

Read Full Background

Corporate Headquarters*

251 Ballardvale Street
Wilmington, Massachusetts 01887

United States

Phone: 781-222-6000
Fax: 978-988-5665

Board Members Memberships*

Director
Director
Director
2009-Present
Director, Chairman of Audit Committee and Member of Strategic Planning & Capital Allocation Committee
2011-Present
Independent Director, Chairman of Strategic Planning & Capital Allocation Committee, Member of Executive Committee and Member of Audit Committee
2011-Present
Director and Member of Finance & Audit Committee

Education*

BA
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$75,000
Total Calculated Compensation$266,331
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRL:US $70.13 USD +0.59

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jacqueline M. Lemke Chief Executive Officer, President and Director
Bioanalytical Systems Inc.
$387.9K
Josef H. von Rickenbach Founder, Chairman and Chief Executive Officer
PAREXEL International Corporation
$883.3K
Colin Shannon Chairman, Chief Executive Officer and President
PRA Health Sciences, Inc.
$1.1M
Ge Li Ph.D.Co-Founder, Chairman, Chief Executive Officer, Member of Strategy & Finance Committee and Member of Corporate Governance & Nominations Committee
WuXi PharmaTech (Cayman) Inc.
--
Miroslav Reljanovic M.D.Founder, Owner, Chief Executive Officer and Director
Ergomed Plc
38.0K GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHARLES RIVER LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.